2 days Milestone Pharmaceuticals’ (MIST) Buy Rating Reaffirmed at HC WainwrightMarketBeat
HC Wainwright restated a “buy” rating and set a $25.00 target price on shares of Milestone Pharmaceuticals in a report on Monday.
XHC Wainwright restated a “buy” rating and set a $25.00 target price on shares of Milestone Pharmaceuticals in a report on Monday.
X